Dariusz Dudek to Everolimus
This is a "connection" page, showing publications Dariusz Dudek has written about Everolimus.
Connection Strength
1.046
-
Vasomotor Response to Nitroglycerine Over 5 Years Follow-Up After Everolimus-Eluting Bioresorbable Scaffold Implantation. JACC Cardiovasc Interv. 2017 04 24; 10(8):786-795.
Score: 0.574
-
Four-year follow-up of the randomised comparison between an everolimus-eluting bioresorbable scaffold and an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II Trial). EuroIntervention. 2018 01 20; 13(13):1561-1564.
Score: 0.151
-
Long-term serial non-invasive multislice computed tomography angiography with functional evaluation after coronary implantation of a bioresorbable everolimus-eluting scaffold: the ABSORB cohort B MSCT substudy. Eur Heart J Cardiovasc Imaging. 2017 May 01; 18(8):870-879.
Score: 0.144
-
Recurrent coronary vasospasm-induced acute coronary syndrome complicated by cardiac arrest. Int J Cardiol. 2015 Apr 01; 184:459-461.
Score: 0.124
-
Scaffold and edge vascular response following implantation of everolimus-eluting bioresorbable vascular scaffold: a 3-year serial optical coherence tomography study. JACC Cardiovasc Interv. 2014 Dec; 7(12):1361-9.
Score: 0.030
-
Comparison between the first and second generation bioresorbable vascular scaffolds: a six month virtual histology study. EuroIntervention. 2011 Apr; 6(9):1110-6.
Score: 0.024